CRP and myeloproliferative disorder: This may explain why there is a very weak correlation between CEC (mainly related to inflammation and CRP) and DD in patients with hepatic disease, in which, differently from MPN patients, DD is mainly influenced by cancer mass activity and coagulation activation, but not by inflammation, as also shown by the low CRP level (see Table 1).